J. Brown

发表

GR196429: a nonindolic agonist at high-affinity melatonin receptors.

M. Dubocovich, C. Browning, S. Foord, 1998, The Journal of pharmacology and experimental therapeutics.

Regional expression of natriuretic peptide receptors during the formation of arterial neointima in the rabbit.

J. Brown, Q. Chen, Q. Chen, 1995, Circulation research.

Binding kinetics differentiates functional antagonism of orexin‐2 receptor ligands

C. Langmead, F. Marshall, J. Brown, 2014, British journal of pharmacology.

Bovril and moclobemide: a novel therapeutic strategy for central autonomic failure

F. Karet, Jamie Brown, J. Brown, 1994, The Lancet.

Discovery of HTL6641, a dual orexin receptor antagonist with differentiated pharmacodynamic properties

M. Congreve, C. Langmead, J. Errey, 2015 .

Sensitization by 3-Antagonist Treatment

M. Petch, J. Brown, J. Hall, 1991 .

Interaction of nonsteroidal anti-inflammatory drugs with antihypertensive and diuretic agents. Control of vascular reactivity by endogenous prostanoids.

C. Dollery, J. Brown, G. Valdés, 1986, The American journal of medicine.

Renal mechanisms of human alpha‐atrial natriuretic peptide in man.

L. Corr, J. Brown, 1987, The Journal of physiology.

DOPA decarboxylase inhibition does not influence the diuretic and natriuretic response to exogenous α-atrial natriuretic peptide in man

R. Causon, V. Aber, J. Brown, 2004, European Journal of Clinical Pharmacology.

Effects of selective channel blocking agents on contractions and action potentials in K+‐depolarized guinea‐pig atria

J. Brown, R. Marshall, E. Winslow, 1985, British journal of pharmacology.

Effects of physiological increments in human alpha-atrial natriuretic peptide and human brain natriuretic peptide in normal male subjects.

M. J. Ashby, M. Ashby, B. Cheung, 1994, Clinical science.

Effects on the 5-hydroxytryptamine-induced head-twitch of drugs with selective actions on alpha1 and alpha2-adrenoceptors

J. Brown, S. Handley, 1982, Neuropharmacology.

Vascular responses to local atrial natriuretic peptide infusion in man.

D. Webb, J. Cockcroft, M. J. Allen, 1988, British journal of clinical pharmacology.

SCH 57790: a novel M2 receptor selective antagonist.

C. Strader, J. Lachowicz, J. Clader, 1999, Life sciences.

Effect of reserpine treatment on low-density lipoproteins in arterial wall and internal organs of rats.

G. Born, J. Brown, G. Weidinger, 2000, Journal of cardiovascular pharmacology.

Effect of atrial natriuretic peptide on renin release in rat isolated glomeruli.

J. Brown, S. Kageyama, 1990, Biochemical and biophysical research communications.

The effect of lithium on the renal response to the dopamine prodrug gludopa in normal man.

P. Rae, T. MacDonald, M. Lee, 1988, British journal of clinical pharmacology.

The renal effects of atrial natriuretic peptide in man are not attenuated by (+)-sulpiride.

T. MacDonald, S. Freestone, M. Lee, 1989, British journal of clinical pharmacology.

The effect of intravenous ketorolac given intraoperatively versus postoperatively on outcome from gynecologic abdominal surgery.

S. Brull, D. O'Hara, P. Balestrieri, 1997, Journal of clinical anesthesia.

Natriuretic peptide receptors in the fetal rat.

J. Brown, Z. Zuo, 1995, The American journal of physiology.

An autocrine system for C-type natriuretic peptide within rat carotid neointima during arterial repair.

J. Brown, Q. Chen, G. Hong, 1997, The American journal of physiology.

Receptor proteins and biological effects of C-type natriuretic peptides in the renal glomerulus of the rat.

J. Brown, Z. Zuo, 1994, The American journal of physiology.

Distribution of atrial natriuretic peptide receptor subtypes in rat brain.

J. Brown, A. Czarnecki, 1990, American Journal of Physiology.

Contractile effects of cysteamine on the guinea‐pig ileum

C. Mcintosh, E. Nishimura, J. Brown, 1984, British journal of pharmacology.

Heterogeneous binding sites for alpha-atrial natriuretic peptide in human umbilical cord and placenta.

J. Polak, J. Wharton, J. Brown, 1991, The American journal of physiology.

The effect of intravenous frusemide on urine dopamine in normal volunteers: studies with indomethacin and carbidopa.

M. Rutter, T. MacDonald, S. Freestone, 1987, Clinical science.

gamma-L-Glutamyl-L-dopa is a dopamine pro-drug, relatively specific for the kidney in normal subjects.

M. Lee, J. Brown, J. Harvey, 1985, Clinical science.

Effects of interrupting the renin‐angiotensin system on sodium excretion in man.

J. Brown, 1988, The Journal of physiology.

Efficacy of carvedilol (BM 14,190), a new beta-blocking drug with vasodilating properties, in exercise-induced ischemia.

A. Maseri, J. Kaski, J. Brown, 1985, The American journal of cardiology.

Effects of felodipine on atrial natriuretic peptide in hypertensive non-insulin dependent diabetes mellitus.

S. Capewell, C. Hajducka, A. Collier, 1990, British journal of clinical pharmacology.

C-type natriuretic peptide and atrial natriuretic peptide receptors of rat brain.

J. Brown, Z. Zuo, 1993, The American journal of physiology.

Renal receptors for atrial and C-type natriuretic peptides in the rat.

J. Brown, Z. Zuo, 1992, The American journal of physiology.

Renal atrial natriuretic peptide receptor subtypes in spontaneously hypertensive rats.

J. Polak, J. Brown, S. P. Salas, 1990, The American journal of physiology.

The effects of intravenous L-dopa on plasma renin activity, renal function, and blood pressure in man

M. Lee, J. Brown, J. Harvey, 2004, European Journal of Clinical Pharmacology.

Domperidone treatment in man inhibits the fall in plasma renin activity induced by intravenous gamma-L-glutamyl-L-dopa.

M. Lee, J. Brown, J. Harvey, 1986, British journal of clinical pharmacology.

Studies with fenoldopam, a dopamine receptor DA1 agonist, in essential hypertension.

M. Lee, J. Brown, J. Harvey, 1986, British journal of clinical pharmacology.

The effect of oral fenoldopam (SKF 82526-J), a peripheral dopamine receptor agonist, on blood pressure and renal function in normal man.

M. Lee, J. Brown, J. Harvey, 1985, British journal of clinical pharmacology.

Lack of effect of ibopamine, a dopamine pro-drug, on renal function in normal subjects.

M. Lee, J. Brown, J. Harvey, 1984, British journal of clinical pharmacology.

SELECTIVE ANTAGONISM BY BENZODIAZEPINES OF NEURONAL RESPONSES TO EXCITATORY AMINO ACIDS IN THE CEREBRAL CORTEX

T. Stone, J. Brown, N. Bernardi, 1979, British journal of pharmacology.

Effects of alpha-adrenoceptor agonists and antagonists and of antidepressant drugs on pre- and postsynaptic alpha-adrenoceptors.

J. Brown, S. Handley, J. Doxey, 1980, European journal of pharmacology.

Dihydropyridine-sensitive calcium channels and barbiturate tolerance and withdrawal

M. Rabbani, J. Brown, H. Little, 1994, Pharmacology Biochemistry and Behavior.